Long-term survivors of more than 5 years in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term survivors of more than 5 years in advanced non-small cell lung cancer

Published:2010-01 Issue:1 Volume:67 Page:120-123
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kaira Kyoichi,Takahashi Toshiaki,Murakami Haruyasu,Tsuya Asuka,Nakamura Yukiko,Naito Tateaki,Endo Masahiro,Yamamoto Nobuyuki

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Chemotherapy for non-small cell lung cancer: Part 1. Early-stage disease;Novell;Oncology (Williston Park),2003

2. Chemotherapy in addition to supportive care improves survival in advanced non-small cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials;J Clin Oncol,2008

3. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

4. American College of Chest Physicians. Chemotherapeutic management of stage IV non-small cell lung cancer;Socinski;Chest,2003

5. Survival determinants in extensive-stage non-small cell lung cancer: the Southwest Oncology Group experience;Albain;J Clin Oncol,1991

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma;BMC Complementary Medicine and Therapies;2023-11-21

2. The combination of high-dose radiotherapy and low-dose radiotherapy patterns can enhance antitumor immunity in non-small cell lung cancer;2023-08-04

3. Extended Survival in Patients With Non–Small-Cell Lung Cancer–Associated Brain Metastases in the Modern Era;Neurosurgery;2023-02-01

4. Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma;OncoTargets and Therapy;2022-09

5. Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings;Clinical Lung Cancer;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3